TNBTD
BIO icon

Trustmark National Bank Trust Department’s Bio-Rad Laboratories Class A BIO Stock Holding History

Trustmark National Bank Trust Department’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-170
Closed -$39K – 588
2018
Q4 		$39K Hold
170
– – ﹤0.01% 358
2018
Q3 		$53K Buy
+170
New +$52.8K 0.01% 350

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Trustmark National Bank Trust Department's BIO Position: Q1 2019 in Review

Trustmark National Bank Trust Department sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2019, closing a stake of 170 shares — an estimated $39K sold.

Trustmark National Bank Trust Department first reported a position in BIO in Q3 2018 and held it in 2 quarters. The position peaked at $53K in Q3 2018. 347 funds tracked by Wall St. Rank hold BIO as of Q1 2019.

  • Trustmark National Bank Trust Department reported no remaining Bio-Rad Laboratories Class A position as of Q1 2019 after selling out during the quarter.
  • Trustmark National Bank Trust Department sold 170 Bio-Rad Laboratories Class A shares in Q1 2019, an estimated $39K.
  • Trustmark National Bank Trust Department first reported a position in Bio-Rad Laboratories Class A in Q3 2018 and held it in 2 quarters.
  • Trustmark National Bank Trust Department's Bio-Rad Laboratories Class A position peaked at $53K in Q3 2018.
  • 347 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2019.

Based on Trustmark National Bank Trust Department's 13F filing for Q1 2019, filed 13 May 2019.